Primary hepatic angiosarcoma: a clinical and pathological analysis.
- Author:
Zhan-bo WANG
1
;
Li-xin WEI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Aged, 80 and over; Antigens, CD34; metabolism; Biomarkers, Tumor; metabolism; Child; Diagnosis, Differential; Female; Follow-Up Studies; Hemangioendothelioma, Epithelioid; pathology; Hemangiosarcoma; diagnosis; metabolism; pathology; surgery; Humans; Ki-67 Antigen; metabolism; Liver Neoplasms; diagnosis; metabolism; pathology; surgery; Magnetic Resonance Imaging; Male; Middle Aged; PTEN Phosphohydrolase; metabolism; Peliosis Hepatis; pathology; Platelet Endothelial Cell Adhesion Molecule-1; metabolism; Survival Rate; von Willebrand Factor; metabolism
- From: Chinese Journal of Pathology 2013;42(6):376-380
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the clinicopathological characteristics, differential diagnosis, and prognosis of primary hepatic angiosarcoma, and to review the literature.
METHODSTwenty cases of primary hepatic angiosarcoma were analyzed by gross examination and light microscopy. Immunostaining was performed to detect the expression of CD34, CD31, FVIIIRAg, CK, GPC-3, Hepatocyte,vimentin, PTEN, desmin, and CD117.
RESULTSThe age of the patients ranged from 7 to 86 years. Eleven cases were male, and 9 were female. All cases showed no specific clinical manifestations and imaging results. Macroscopically, the tumors showed diffuse multi-nodular or single nodular patterns with hemorrhage. Microscopically, there were various patterns such as cavernous vascular space and epithelioid hemangioendothelioma-like appearances; however, specific pathological diagnostic features of angiosarcoma still existed in all cases. All of the cases expressed at least one of the three immunohistochemical markers: CD31, CD34 and/or FVIIIRag. Ten cases had PTEN low expression. Ki-67 proliferative index was more than 10% in all cases. None of cases expressed desmin, CD117, GPC-3 or Hepatocyte.
CONCLUSIONSPrimary hepatic angiosarcoma is a rare malignant tumor. Detailed morphological observation and using various vascular endothelial immunohistochemical markers can help to establish the diagnosis accurately.
